Observational studyProstate cancer and prostatic diseases2023

Cardiovascular risk of gonadotropin-releasing hormone antagonist versus agonist in men with prostate cancer: an observational study in Taiwan.

Yu-Hsuan Joni Shao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.